High infiltration of tumor-infiltrating CD8+, CD4+, and FOXp3+ regulatory (Tregs) T cells and low CD163+ M2 macrophages (TAMs) were found to be significantly correlated with a longer overall survival in eCCA patients4. The gene discussed is CD163; the disease is neoplasm.